124 related articles for article (PubMed ID: 8175775)
1. Functional block for 1 alpha,25-dihydroxyvitamin D3-mediated gene regulation in human B lymphocytes.
Morgan JW; Reddy GS; Uskokovic MR; May BK; Omdahl JL; Maizel AL; Sharma S
J Biol Chem; 1994 May; 269(18):13437-43. PubMed ID: 8175775
[TBL] [Abstract][Full Text] [Related]
2. Requirements for induction of vitamin D-mediated gene regulation in normal human B lymphocytes.
Morgan JW; Morgan DM; Lasky SR; Ford D; Kouttab N; Maizel AL
J Immunol; 1996 Oct; 157(7):2900-8. PubMed ID: 8816395
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
Healy KD; Zella JB; Prahl JM; DeLuca HF
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor.
Koeffler HP; Bishop JE; Reichel H; Singer F; Nagler A; Tobler A; Walka M; Norman AW
Mol Cell Endocrinol; 1990 Mar; 70(1):1-11. PubMed ID: 2160380
[TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3 up-regulates TLR10 while down-regulating TLR2, 4, and 5 in human monocyte THP-1.
Verma R; Jung JH; Kim JY
J Steroid Biochem Mol Biol; 2014 May; 141():1-6. PubMed ID: 24373795
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
[TBL] [Abstract][Full Text] [Related]
9. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
Yao J; Kathpalia P; Bushinsky DA; Favus MJ
J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
[TBL] [Abstract][Full Text] [Related]
10. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.
Christakos S; Raval-Pandya M; Wernyj RP; Yang W
Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):361-71. PubMed ID: 8687373
[TBL] [Abstract][Full Text] [Related]
11. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
Ellison TI; Eckert RL; MacDonald PN
J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
[TBL] [Abstract][Full Text] [Related]
12. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
Imai Y; Pike JW; Koeffler HP
Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
[TBL] [Abstract][Full Text] [Related]
13. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production.
Provvedini DM; Tsoukas CD; Deftos LJ; Manolagas SC
J Immunol; 1986 Apr; 136(8):2734-40. PubMed ID: 3007606
[TBL] [Abstract][Full Text] [Related]
14. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of gene transcription in subpopulations of human B lymphocytes by vitamin D3.
Morgan JW; Sliney DJ; Morgan DM; Maizel AL
Endocrinology; 1999 Jan; 140(1):381-91. PubMed ID: 9886849
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects.
Takeuchi A; Reddy GS; Kobayashi T; Okano T; Park J; Sharma S
J Immunol; 1998 Jan; 160(1):209-18. PubMed ID: 9551973
[TBL] [Abstract][Full Text] [Related]
17. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T
Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
19. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
20. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]